Your browser doesn't support javascript.
loading
Severe SARS-CoV-2 infection in a 32-week pregnant woman treated with Remdesivir-Dexamethasone combination therapy: A case report.
Alavi, Seyed Mohammad Amin; Bahrami, Samaneh; Najafian, Mahin; Hoori, Mina.
Afiliação
  • Alavi SMA; Student Research Committee Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
  • Bahrami S; Division of Perinatology, Department of Obstetrics and Gynecology, Imam Khomeini Hospital Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
  • Najafian M; Division of Perinatology, Department of Obstetrics and Gynecology, Imam Khomeini Hospital Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
  • Hoori M; Student Research Committee Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran.
Clin Case Rep ; 10(8): e6241, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35979383
This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID-19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combination with dexamethasone during pregnancy.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2022 Tipo de documento: Article